We wish to inform you that in line with its strategy to exit non-core business/investment and pursuant to the approval granted by its Board of Directors in its meeting held on 25th March, 2023, Dalmia Cement (Bharat) Limited (DCBL), a material wholly owned subsidiary of the Company, has entered into a binding agreement to sell its entire investment of 1,87,23,743 equity Shares of Rs. 10 each (42.36% of share capital) of Dalmia Bharat Refractories Limited (DBRL), an associate company, at a consideration of Rs. 800 cr. to M/s Sarvapriya Healthcare Solutions Private Limited (Sarvapriya), a promoter group Company. The transaction will be consummated within 30 days i.e. on or before 25th April, 2023 and the consideration for transfer of investment shall be received by DCBL as per attached file.\r\n